PHARMA-TECH A/S: Financial statements 2023
CVR: 32940897
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMA-TECH A/S (CVR 32940897) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 24,106,590 and a net result of DKK 6,453,098 compared with DKK 4,335,927 the year before. That is an increase of 24.7% compared with the year before. Equity in the 2023 report amounted to DKK 24,220,453. The solvency ratio was 59.7%. The company had 23 employees in the financial year.
- Gross Profit
- DKK 24,106,590
- Profit/Loss
- DKK 6,453,098
- Equity
- DKK 24,220,453
- Total Assets
- DKK 40,568,330
- Employees
- 23
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 24.1 mio. | 6.5 mio. | 24.2 mio. | 23 |
| 2022 | - | 19.3 mio. | 4.3 mio. | 19.8 mio. | 21 |
| 2021 | - | 18 mio. | 3.1 mio. | 17.4 mio. | 21 |
| 2020 | - | 29 mio. | 11.9 mio. | 22.3 mio. | 21 |
| 2019 | - | 15.3 mio. | 3.5 mio. | 10.5 mio. | 20 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMA-TECH A/S has published its annual report for 2022. Gross profit came to DKK 19,333,355, and the net result was DKK 4,335,927.
About PHARMA-TECH A/S
PHARMA-TECH A/S is a Danish company of the type Aktieselskab based in Randers SV, founded in 2010. The company is registered under the industry Fremstilling af plastemballage. The management consists of Morten Hart Johansen. The board consists of Claus Wædeled (chair), Morten Hart Johansen and Rikke Winther. The company is owned by JoWin Holding ApS. The company has 24 employees (2018). In 2025, the company reported a gross profit of DKK 32,243,339 and a net result of DKK 5,636,893 compared with DKK 6,599,234 the year before. Equity in the 2025 report amounted to DKK 24,456,581.